Complex of peptide fractions, acquired from bronchial tubes mucous membrane of young animals. Discharged peptides possess selective action to cells of bronchial tubes mucous membrane, normalize metabolism, increase their functional activity.
The efficiency of 'Taxorest' medicine was defined at clinical studying. It is effective for restoration of bronchial tubes functional activity at violations of various genesis, including influence of external environment extreme factors, after acute and chronic diseases of respiratory system of infectious and noninfectious genesis, including chronic bronchitis and bronchitis of smokers, at bronchial asthma, and also at aging for maintenance of respiratory system function.
- chronic bronchitis,
- bronchitis of smoker,
- bronchial asthma,
- chronic obstructive pulmonary disease,
- chronic cardiac deficiency,
- after diseases of bronchial tubes and lungs of various genesis.
(Per 1 capsule): peptide complex A-19 (peptides of bronchial mucosa), microcrystalline cellulose (E460, the flowing agent), gelatin (encapsulating agent), sugar beet (binding filler), lactose (excipient-humectant), starch (stabilizer), tween-80 (emulsifier), titanium dioxide (E171, coloring agent for capsules).
How to apply:
Adults 1-2 capsules 1-2 times a day, with meal. Course duration is 1-3 months. Reasonable to repeat a course after 1-3 months.